Article Versions Notes

Müller C, De Prado Leal M, Dominietto MD, Umbricht CA, Safai S, Perrin RL, Egloff M, Bernhardt P, van der Meulen NP, Weber DC, et al. Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute. Pharmaceutics. 2019; 11(9):450. https://doi.org/10.3390/pharmaceutics11090450

Müller, Cristina, Maria De Prado Leal, Marco D. Dominietto, Christoph A. Umbricht, Sairos Safai, Rosalind L. Perrin, Martina Egloff, Peter Bernhardt, Nicholas P. van der Meulen, Damien C. Weber, and et al. 2019. "Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute" Pharmaceutics 11, no. 9: 450. https://doi.org/10.3390/pharmaceutics11090450

Müller, C., De Prado Leal, M., Dominietto, M. D., Umbricht, C. A., Safai, S., Perrin, R. L., Egloff, M., Bernhardt, P., van der Meulen, N. P., Weber, D. C., Schibli, R., & Lomax, A. J. (2019). Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute. Pharmaceutics, 11(9), 450. https://doi.org/10.3390/pharmaceutics11090450